ISDS yields 9.19% · MRK yields 3.25%● Live data
📍 ISDS pulled ahead of the other in Year 1
Combined, ISDS + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ISDS + MRK for your $10,000?
The investment seeks to track the investment results (before fees and expenses) of the Invesco Strategic Developed ex-US Small Company Index (the "underlying index"). The fund generally will invest at least 80% of its total assets in securities that comprise the underlying index and American depositary receipts ("ADRs") and global depositary receipts ("GDRs") that are based on securities in the underlying index. The underlying index is designed to measure the performance of equity securities issued by higher quality, small-business-sized companies located in countries designated as developed market countries (excluding the U.S.). The fund is non-diversified.
Full ISDS Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.